Novo Nordisk is seeking novel cell delivery solutions to improve cell therapy treatments in humans. Specifically, the team is interested in device, biomaterial and formulation approaches to improve efficacy in Type 1 Diabetes, Chronic Heart failure and Parkinson’s Disease.
Approaches of Interest:
- Biomaterial or formulation approaches for the preparation and administration of viable and healthy cells at point of delivery (i.e. recovery from cryopreservation, resuspension and delivery).
- Key challenges include limiting cell stress (shear, temperature and...